Cambridge Epigenetix logo

Cambridge Epigenetix

Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.

1

Funding Rounds

$88.0m

Money raised

Overview

Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.

Funding series

Funding Series Analysis

The company Cambridge Epigenetix has raised a total of $88m in funding over 1 rounds.

Key Insights:

  • Cambridge Epigenetix November 2021 Series D Funding Round: $88m
Cambridge Epigenetix logo
Cambridge Epigenetix November 2021 Series D Funding Round $88m